At2g18630 Antibody

What is AT2G18630 and where is it found?

AT2G18630 is a UPF0496 family protein found in Arabidopsis thaliana. It is a full-length protein consisting of 393 amino acids. The protein is classified under the UPF0496 protein family, which contains proteins with structures that have been determined but whose functions remain largely uncharacterized. AT2G18630 is encoded by a gene located on chromosome 2 of the Arabidopsis genome .

What are the known structural characteristics of AT2G18630?

AT2G18630 is a full-length protein (1-393 amino acids) that can be expressed as a recombinant protein with a histidine tag. The protein has been successfully expressed in E. coli expression systems, suggesting it is amenable to heterologous expression and purification for structural and functional studies . While detailed structural information is limited in the available search results, its classification in the UPF0496 family suggests it may share structural features with other members of this protein family.

How can I obtain recombinant AT2G18630 for antibody production?

Recombinant AT2G18630 protein for antibody production can be obtained through E. coli expression systems using His-tag purification methods. The protein has been successfully expressed as a full-length recombinant protein with a histidine tag, as indicated by commercial availability of such proteins . When designing expression constructs, consider using the complete coding sequence (1-393 amino acids) and appropriate prokaryotic expression vectors with histidine tag sequences for affinity purification.

What considerations should be made when designing an AT2G18630 antibody-based experiment?

When designing an AT2G18630 antibody-based experiment, several critical factors must be considered to ensure valid and reproducible results. First, clearly define your research question and identify the independent variable (e.g., environmental stress conditions) and dependent variable (e.g., AT2G18630 protein expression levels) . Consider potential confounding variables that might affect protein expression or antibody binding.

For antibody selection, determine whether polyclonal or monoclonal antibodies are more appropriate for your specific research question. Polyclonal antibodies might offer broader epitope recognition but with potential cross-reactivity concerns, while monoclonal antibodies provide higher specificity but might be less robust to protein modifications.

Additionally, plan appropriate controls for validating antibody specificity, including negative controls (samples from knockout mutants) and positive controls (samples with known AT2G18630 expression). Based on experimental design principles, consider between-subjects or within-subjects designs depending on your research question and available resources .

How can I validate the specificity of an AT2G18630 antibody?

Validating the specificity of an AT2G18630 antibody requires a systematic approach with multiple complementary methods:

• Western blot analysis using wildtype Arabidopsis thaliana extracts compared with AT2G18630 knockout or knockdown mutants. A specific antibody should show reduced or absent signal in the mutant samples.

• Immunoprecipitation followed by mass spectrometry to confirm the antibody pulls down AT2G18630 and identify any cross-reactive proteins.

• Peptide competition assays, where pre-incubation of the antibody with the immunizing peptide should abolish or significantly reduce signal in immunodetection methods.

• Immunolocalization studies compared with fluorescent protein-tagged AT2G18630 to confirm similar localization patterns.

• Testing antibody reactivity against recombinant AT2G18630 protein and closely related family members to assess cross-reactivity.

Similar approaches have been used for validating antibodies against other Arabidopsis proteins, such as ATG8, where comparisons between wildtype and atg5 mutants (which lack the protein of interest) serve as essential controls for antibody specificity .

What is the best method to detect AT2G18630 protein expression in different plant tissues?

For detecting AT2G18630 protein expression across different plant tissues, a combination of approaches is recommended for comprehensive analysis:

Western blotting offers a quantitative approach for comparing expression levels across tissues. Following the protocol similar to ATG8 detection , tissue samples should be homogenized in extraction buffer, fractionated by ultracentrifugation if subcellular localization is of interest, and separated on SDS-PAGE gels (12-15% with urea can improve resolution of plant proteins). When interpreting results, include appropriate controls such as recombinant AT2G18630 protein as a positive control.

Immunohistochemistry provides spatial information about protein localization within tissues. Tissue fixation, embedding, sectioning, and antibody incubation protocols should be optimized specifically for plant tissues. Confocal microscopy with fluorescently-labeled secondary antibodies can reveal cellular and subcellular localization patterns.

For quantitative comparison across multiple samples, consider enzyme-linked immunosorbent assay (ELISA) with the AT2G18630 antibody, which can provide more precise quantification than Western blotting for high-throughput analysis.

How can I use AT2G18630 antibodies to study protein-protein interactions?

AT2G18630 antibodies can be employed in several complementary approaches to study protein-protein interactions:

Co-immunoprecipitation (Co-IP) is a powerful method where AT2G18630 antibodies are used to isolate the protein along with its interaction partners from plant extracts. Precipitated complexes are then analyzed by mass spectrometry or Western blotting with antibodies against suspected interaction partners. When designing Co-IP experiments, consider using mild lysis conditions to preserve protein-protein interactions and include appropriate negative controls (IgG or pre-immune serum).

Proximity ligation assay (PLA) offers in situ detection of protein interactions with high sensitivity. This technique uses two primary antibodies (one against AT2G18630 and another against a potential interacting protein) and special secondary antibodies that generate a signal only when the two proteins are in close proximity.

For validation of direct interactions, pull-down assays using recombinant AT2G18630 protein can be combined with antibody detection of putative interacting partners. These approaches would be similar to those used for studying interactions of other plant proteins, such as those involved in autophagy pathways .

What protocol should I follow for subcellular fractionation when using AT2G18630 antibodies?

For subcellular fractionation studies with AT2G18630 antibodies, adapt the protocol used for ATG8 in Arabidopsis :

• Harvest approximately 0.2 g of Arabidopsis seedlings (5-day-old recommended for consistent tissue).

• Freeze tissues in liquid nitrogen and grind thoroughly in a mortar.

• Add 2x extraction buffer containing protease inhibitor cocktail (PIC) without detergent to the ground tissue.

• After slow defrosting on ice, transfer the homogenate to a microcentrifuge tube and centrifuge at 1,000 × g for 5 minutes at 4°C to remove unbroken cells and debris.

• Transfer the supernatant to an ultracentrifuge tube and centrifuge at 100,000 × g for 45 minutes at 4°C.

• Carefully collect the supernatant (soluble fraction) and the pellet (membrane fraction).

• Wash the pellet gently with 1x extraction buffer containing PIC.

• Resuspend the pellet in 1x extraction buffer with PIC and 1% Triton X-100 to solubilize membrane proteins.

• Analyze both fractions by Western blotting with AT2G18630 antibodies.

This approach allows for determination of whether AT2G18630 is predominantly cytosolic, membrane-associated, or distributed between both compartments .

How can I use AT2G18630 antibodies to study post-translational modifications?

Studying post-translational modifications (PTMs) of AT2G18630 using antibodies requires specialized approaches:

For phosphorylation analysis, use phospho-specific antibodies if available, or combine general AT2G18630 antibodies with techniques like Phos-tag SDS-PAGE, which causes a mobility shift in phosphorylated proteins. Immunoprecipitate AT2G18630 with the antibody followed by phospho-specific staining methods or mass spectrometry analysis.

For studying lipidation (similar to ATG8-PE detection), utilize membrane fractionation techniques as described in the ATG8 lipidation assay protocol . The lipidated form of proteins typically shows different mobility in SDS-PAGE gels with urea (15% acrylamide with 6M urea is recommended). Compare samples with and without treatments that might affect lipidation status.

For ubiquitination studies, perform immunoprecipitation with AT2G18630 antibodies followed by Western blotting with ubiquitin antibodies, or vice versa. Treatment with proteasome inhibitors before protein extraction can enhance detection of ubiquitinated forms.

Always include appropriate controls: positive controls (samples with known PTM induction), negative controls (samples treated with specific PTM inhibitors), and technical controls (recombinant AT2G18630 with or without in vitro modification).

How do I troubleshoot non-specific binding when using AT2G18630 antibodies?

Non-specific binding is a common challenge when working with plant protein antibodies. To troubleshoot this issue with AT2G18630 antibodies:

• Optimize blocking conditions by testing different blocking agents (BSA, non-fat milk, commercial blocking buffers) and concentrations. For plant samples, 5% milk in PBS has been effective for ATG8 antibodies .

• Adjust antibody concentration through titration experiments. Start with the manufacturer's recommended dilution and test serial dilutions to find the optimal concentration that maximizes specific signal while minimizing background.

• Increase stringency of washing steps by adding higher concentrations of detergent (0.1-0.5% Tween-20) or salt (up to 500 mM NaCl) to wash buffers.

• Pre-absorb the antibody with plant extract from knockout mutants or with proteins known to cause cross-reactivity.

• Consider using more specific detection methods like immunoprecipitation followed by mass spectrometry to confirm the identity of detected proteins.

• If working with multiple isoforms of AT2G18630, be aware that antibodies may detect cross-reacting species with similar sizes, as observed with ATG8 isoforms in Arabidopsis . Include appropriate controls (such as knockout mutants) to correctly identify the specific protein band.

How can I quantify changes in AT2G18630 protein levels under different stress conditions?

To quantify changes in AT2G18630 protein levels under different stress conditions:

• Design a systematic experimental approach with clearly defined independent variables (stress conditions) and dependent variables (AT2G18630 protein levels) . Include appropriate controls for each stress condition.

• Ensure consistent sample collection by harvesting tissues at the same developmental stage and time of day to minimize variation from circadian and developmental factors.

• For Western blot quantification, use loading controls appropriate for plant tissues under stress conditions (proteins known to remain stable under the specific stresses being tested).

• Perform at least three biological replicates for statistical validity and include technical replicates within each biological replicate.

• For precise quantification, consider using fluorescently-labeled secondary antibodies and scanning with a fluorescence imager, which provides a broader linear range than chemiluminescence.

• Analyze data using appropriate statistical methods to determine significant differences between conditions. For multiple treatment comparisons, use ANOVA followed by post-hoc tests.

Below is a sample experimental design table for studying AT2G18630 response to different stresses:

How do I interpret contradictory results in AT2G18630 antibody-based experiments?

Contradictory results in AT2G18630 antibody experiments can arise from various sources and require systematic troubleshooting:

Antibody specificity issues may lead to detection of multiple bands or inconsistent signals. To address this, validate your antibody using knockout mutants as negative controls, similar to the approach used with atg5 mutants in ATG8 studies . Multiple isoforms of related proteins can cause conflicting results, as observed with ATG8 isoforms in Arabidopsis that have different SDS-PAGE mobilities .

Experimental condition variations can significantly impact results. Standardize protein extraction methods, sample handling, and storage conditions. For plant tissues specifically, ensure consistent growth conditions and developmental stages, as protein expression can vary widely throughout development.

Document all experimental parameters meticulously and systematically vary one parameter at a time to identify sources of variability. Statistical analysis of multiple replicates can help determine whether contradictions reflect biological variability or technical issues.

What are the most common pitfalls when using AT2G18630 antibodies for co-localization studies?

When using AT2G18630 antibodies for co-localization studies, researchers should be aware of several common pitfalls:

Fixation artifacts can significantly alter protein localization in plant tissues. Different fixatives (formaldehyde, glutaraldehyde, methanol) may preserve different cellular structures with varying efficacy. Test multiple fixation protocols to determine the optimal method for AT2G18630 detection while preserving cellular architecture.

Antibody cross-reactivity may lead to false positive signals. Validate antibody specificity using knockout mutants as negative controls and recombinant protein as a positive control. For co-localization studies specifically, control for bleed-through between fluorescent channels by including single-label controls.

Resolution limitations can lead to false interpretations of co-localization. Conventional fluorescence microscopy has limited resolution (~200 nm), which can make proteins appear co-localized when they are actually separated but below the resolution limit. Consider using super-resolution microscopy techniques for more definitive co-localization analysis.

When interpreting co-localization data, perform quantitative analysis using co-localization coefficients (Pearson's, Mander's) rather than relying solely on visual assessment. Remember that co-localization indicates proximity but not necessarily direct interaction; complementary approaches like FRET or PLA may be needed to confirm direct interactions.

How can I integrate AT2G18630 antibody data with other -omics approaches for comprehensive pathway analysis?

Integrating AT2G18630 antibody data with other -omics approaches enables comprehensive pathway analysis and functional characterization:

• Combine protein expression data from immunoblotting with transcriptomics data (RNA-seq or microarray) to identify correlations between mRNA and protein levels. Discrepancies may indicate post-transcriptional regulation mechanisms affecting AT2G18630.

• Integrate immunoprecipitation followed by mass spectrometry (IP-MS) to identify AT2G18630 interaction partners with phosphoproteomics data to understand how phosphorylation states affect these interactions under different conditions.

• Correlate subcellular localization data from immunofluorescence studies with metabolomics data to link AT2G18630 localization patterns to specific metabolic states or responses.

• Use network analysis tools to place AT2G18630 and its interactors within larger biological networks, leveraging publicly available protein-protein interaction databases for Arabidopsis.

• When analyzing autophagy-related processes, combine AT2G18630 antibody data with ATG8 lipidation assays to assess potential connections to autophagy pathways, as demonstrated for other Arabidopsis proteins .

• For functional validation of hypotheses generated through integrated analysis, design targeted experiments using genetic approaches (e.g., CRISPR/Cas9 gene editing, overexpression, or complementation studies) combined with antibody-based protein detection.

This multi-faceted approach can help place AT2G18630 within its biological context and elucidate its function in plant cellular processes.